Found: 168
Select item for more details and to access through your institution.
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 912, doi. 10.1111/head.14797
- By:
- Publication type:
- Article
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1027, doi. 10.1111/head.14729
- By:
- Publication type:
- Article
Plain Language Summary Publication: Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1070, doi. 10.1111/head.14786
- By:
- Publication type:
- Article
Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) study.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01834-y
- By:
- Publication type:
- Article
Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card survey.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03732-x
- By:
- Publication type:
- Article
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 750, doi. 10.1111/head.14753
- By:
- Publication type:
- Article
Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 3, p. 511, doi. 10.1007/s40122-024-00583-9
- By:
- Publication type:
- Article
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 469, doi. 10.1111/head.14721
- By:
- Publication type:
- Article
Prevalence and burden of migraine in the United States: A systematic review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 5, p. 516, doi. 10.1111/head.14709
- By:
- Publication type:
- Article
Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 361, doi. 10.1111/head.14684
- By:
- Publication type:
- Article
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuse.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01725-2
- By:
- Publication type:
- Article
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 2, p. 156, doi. 10.1111/head.14664
- By:
- Publication type:
- Article
Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 12, p. 5692, doi. 10.1007/s00415-023-11880-2
- By:
- Publication type:
- Article
Pre- and post-headache phases of migraine: multi-country results from the CaMEO – International Study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01683-1
- By:
- Publication type:
- Article
Impact of monthly headache days on migraine‐related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1448, doi. 10.1111/head.14629
- By:
- Publication type:
- Article
The Exploration of Cannabis and Cannabinoid Therapies for Migraine.
- Published in:
- Current Pain & Headache Reports, 2023, v. 27, n. 9, p. 339, doi. 10.1007/s11916-023-01144-z
- By:
- Publication type:
- Article
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, p. 1, doi. 10.1186/s10194-023-01655-5
- By:
- Publication type:
- Article
Harassment in the headache field: a global web-based cross-sectional survey.
- Published in:
- Cephalalgia, 2023, v. 43, n. 8, p. 1, doi. 10.1177/03331024231193099
- By:
- Publication type:
- Article
Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 7, p. 953, doi. 10.1111/head.14521
- By:
- Publication type:
- Article
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
- Published in:
- Cephalalgia, 2023, v. 43, n. 6, p. 1, doi. 10.1177/03331024231180611
- By:
- Publication type:
- Article
Living in society, living with migraine: Editorial for the 2022 Members' Choice Award paper.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 714, doi. 10.1111/head.14530
- By:
- Publication type:
- Article
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 5, p. 683, doi. 10.1111/head.14460
- By:
- Publication type:
- Article
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00552-4
- By:
- Publication type:
- Article
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 441, doi. 10.1111/head.14484
- By:
- Publication type:
- Article
Longitudinal assessment of comorbidities and co‐occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health).
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 2, p. 243, doi. 10.1111/head.14457
- By:
- Publication type:
- Article
Eptinezumab improved patient‐reported outcomes in patients with migraine and medication‐overuse headache: Subgroup analysis of the randomized PROMISE‐2 trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 2, p. 264, doi. 10.1111/head.14434
- By:
- Publication type:
- Article
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The unique role of stigma in migraine‐related disability and quality of life.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 10, p. 1354, doi. 10.1111/head.14401
- By:
- Publication type:
- Article
Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 6, p. 690, doi. 10.1111/head.14295
- By:
- Publication type:
- Article
Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 6, p. 755, doi. 10.1111/head.14312
- By:
- Publication type:
- Article
The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221095902
- By:
- Publication type:
- Article
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future research.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 262, doi. 10.1177/03331024211038526
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 3, p. 284, doi. 10.1111/head.14274
- By:
- Publication type:
- Article
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01387-y
- By:
- Publication type:
- Article
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-021-01376-7
- By:
- Publication type:
- Article
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 2, p. 122, doi. 10.1111/head.14259
- By:
- Publication type:
- Article
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 2, p. 159, doi. 10.1111/head.14258
- By:
- Publication type:
- Article
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 20, doi. 10.1177/03331024211048507
- By:
- Publication type:
- Article
The importance of an early onset of migraine preventive disease control: A roundtable discussion.
- Published in:
- Cephalalgia Reports, 2022, v. 5, p. 1, doi. 10.1177/25158163221134593
- By:
- Publication type:
- Article
The importance of an early onset of migraine prevention: an evidence-based, hypothesisdriven scoping literature review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221095902
- By:
- Publication type:
- Article
Is there a causal relationship between stress and migraine? Current evidence and implications for management.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01369-6
- By:
- Publication type:
- Article
Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature study.
- Published in:
- Journal of Patient-Reported Outcomes, 2021, v. 5, n. 1, p. 1, doi. 10.1186/s41687-021-00401-2
- By:
- Publication type:
- Article
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
- Published in:
- Cephalalgia, 2021, v. 41, n. 11/12, p. 1152, doi. 10.1177/03331024211010305
- By:
- Publication type:
- Article
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1376, doi. 10.1111/head.14196
- By:
- Publication type:
- Article
Health-related quality of life in tension-type headache: a population-based study.
- Published in:
- Scandinavian Journal of Pain, 2021, v. 21, n. 4, p. 778, doi. 10.1515/sjpain-2020-0166
- By:
- Publication type:
- Article
The value of the patient perspective in understanding the full burden of migraine.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Learning the full impact of migraine through patient voices: A qualitative study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 7, p. 1004, doi. 10.1111/head.14151
- By:
- Publication type:
- Article
Updated process for American Headache Society Guidelines.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Erenumab patient characteristics, medication adherence, and treatment patterns in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 590, doi. 10.1111/head.14068
- By:
- Publication type:
- Article
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 628, doi. 10.1111/head.14103
- By:
- Publication type:
- Article